The board of directors of Neway Group Holdings Limited announce that with effect from 28 September 2023, Ms. Sin Chui Pik, Christine ("Ms. Sin") has been appointed as (i) an independent non-executive Director; (ii) a member of the audit committee of the Board ("Audit Committee"); and (iii) a member of the remuneration committee of the Board ("Remuneration Committee"). The Board would like to express its warmest welcome to Ms. Sin in joining the Company. Ms. Sin, aged 44, obtained a bachelor's degree of business administration in accounting from Hong Kong Baptist University in 2001. She is a member of the Hong Kong Institute of Certified Public Accountants and a fellow of the Association of Chartered Certified Accountants. Ms. Sin has over 21 years of accounting and auditing experience. Ms. Sin worked for Deloitte Touche Tohmatsu, an international public accounting and auditing firm, from 2001 to 2004 and from 2005 to 2014, where she most recently served as a manager. Ms. Sin is currently an executive director of Medicskin Holdings Limited ("Medicskin", together with its subsidiaries, "Medicskin Group"), a company listed on GEM of The Stock Exchange of Hong Kong Limited ("Stock Exchange") with stock code 8307. She has also been the chief financial officer of Medicskin Group and the company secretary of Medicskin since 2014. Following the appointment of Ms. Sin as an independent non-executive Director, a member of the Audit Committee and a member of the Remuneration Committee: the Board comprises eight members, including two executive Directors, three non-
executive Directors and three independent non-executive Directors, which is in compliance with the requirements under Rules 3.10(1) and 3.10A of the Listing Rules
that the Board must include at least three independent non-executive Directors and that the independent non-executive Directors must represent at least one-third of the Board; the Audit Committee comprises three members, including two independent non- executive Directors and one non-executive Director, which is in compliance with the
requirements under Rule 3.21 of the Listing Rules that the Audit Committee must comprise a minimum of three members and that the majority of its members must be
independent non-executive Directors; and the Remuneration Committee comprises three members, including two independent non-executive Directors and one non-executive Director, which is in compliance with the requirement under Rule 3.25 of the Listing Rules that it must comprise a majority of independent non-executive Directors.